CGP - Product launch next Wednesday of the Turbine (a nasal dilation device that increases oxygen intake by 38%), expect an aggressive and disruptive marketing campaign targeted at endurance athletes. Campany is renamed to Rhinomed next week. SP have been going crazy (both ways) this week. Will be very interesting to see how the market reacts to the launch. Many possible applications of the Turbine.
ACG - Finished the week on a high. Still looking good as a growth company with a PE ratio of 11.6
AHZ - Hoping for some more good news this side of Xmas
ALT - A triple threat company. Two exciting products expected to thit the market in the next 6 months. One more in development.
NAN - Quietly going about its business growing sales. Not many traders in this stock, so doesn't get the wild swings of some other biotechs of its size.
ADO - Weekend reading trying to get my head around this company and their technology.
